Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
Clinical trial NCT04476485 · RECRUITING
Trial details
- NCT number
- NCT04476485
- Sponsor
- Shengjing Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-19
- Primary completion
- 2021-12-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.